WASHINGTON, April 12 (Reuters) - A top Democrat in the U.S.
House of Representatives on Tuesday called on Valeant
Pharmaceuticals International Inc VRX.TO for more details on
its relationship with Philidor RX services and chided the
company for not providing Congress any documents or other
requested information.
"Your refusal to cooperate fully with Congress is extremely
troubling and reflects a pattern of obstruction that impairs our
ability to protect the American people against your company's
exorbitant price increases," U.S. Representative Elijah Cummings
wrote in a letter to Valeant Chief Executive Michael Pearson (LON:PSON).
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
U.S. Representative Cummings' letter to Valeant: http://democrats.oversight.house.gov/sites/democrats.oversight.house.gov/files/documents/2016-04-12.EEC
to Pearson re Prescription Drug Prices.pdf
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>